Jake Nunn
Director/Board Member presso OVES MEDI
Patrimonio netto: 79 $ in data 31/03/2024
Profilo
Mr. Jake R.
Nunn, CFA MBA, is a Venture Partner at SR One Capital Management LP, an Independent Director at Regulus Therapeutics, Inc., an Independent Non-Executive Director at Addex Therapeutics Ltd., an Independent Director at Trevena, Inc. and a Member at CFA Society of San Francisco.
He is on the Board of Directors at Humanetics Corp., Oventus Medical Ltd., Regulus Therapeutics, Inc., Addex Therapeutics Ltd.
and Trevena, Inc. Mr. Nunn was previously employed as a Non-Executive Director by Hexima Ltd., an Independent Director by Dermira, Inc., an Independent Director by Transcept Pharma, Inc., an Independent Director by Trivascular Technologies, Inc., a Partner by NEA Management Co. LLC, a Principal by MPM BioEquities Adviser LLC, a Portfolio Manager by Franklin Templeton Investments Corp., an Investment Banker by Alex.
Brown & Sons, Inc., and a Portfolio Manager by Franklin Resources, Inc. He also served on the board at Qool Therapeutics, Inc., Hyperion Therapeutics, Inc., TriVascular, Inc., Nicox Ophthalmics, Inc. and Trivascular2, Inc. He received his undergraduate degree from Dartmouth College and an MBA from Stanford Graduate School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
TREVENA, INC.
0.00% | 09/02/2024 | 171 ( 0.00% ) | 79 $ | 31/03/2024 |
10/08/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Jake Nunn
Società | Posizione | Inizio |
---|---|---|
TREVENA, INC. | Director/Board Member | 01/07/2013 |
ADDEX THERAPEUTICS LTD | Director/Board Member | 01/06/2018 |
REGULUS THERAPEUTICS INC. | Director/Board Member | 11/06/2019 |
OVES MEDI | Director/Board Member | 25/02/2020 |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Director/Board Member | 09/08/2022 |
CFA Society of San Francisco
CFA Society of San Francisco Miscellaneous Commercial ServicesCommercial Services CFA Society of San Francisco provides educational services. It offers a multi-review course which provides structured, classroom-based approach to preparing for the examination. The firm focuses on the assigned materials in the study guides from CFA Institute, with an emphasis on the Learning Outcome Statements (LOS). The company was founded in 1929 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 22/07/2009 |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Private Equity Investor | 01/01/2023 |
Precedenti posizioni note di Jake Nunn
Società | Posizione | Fine |
---|---|---|
HEXIMA LIMITED | Director/Board Member | 05/09/2023 |
Qool Therapeutics, Inc.
Qool Therapeutics, Inc. BiotechnologyHealth Technology Qool Therapeutics, Inc. develops non-invasive temperature management therapies to induce therapeutic hypothermia. The company was founded by Amir Belson in 2005 and is headquartered in Menlo Park, CA. | Director/Board Member | 01/06/2021 |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Jake Nunn
Dartmouth College | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
FRANKLIN RESOURCES, INC. | Finance |
HEXIMA LIMITED | Health Technology |
ADDEX THERAPEUTICS LTD | Health Technology |
TREVENA, INC. | Health Technology |
REGULUS THERAPEUTICS INC. | Health Technology |
Aziende private | 16 |
---|---|
Franklin Templeton Investments Corp.
Franklin Templeton Investments Corp. Investment ManagersFinance Franklin Templeton Investments Corp. (FTI) is a SEC-registered investment advisor and mutual fund manager headquartered in Toronto, Canada. The firm was founded in 2000 and they are a subsidiary of Templeton International, Inc. Their ultimate parent is Franklin Resources, Inc. (NYSE: BEN), a global investment management company also known as Franklin Templeton Investments. FTI provides investment advisory and portfolio management services with clients in jurisdictions worldwide, which include registered open-end and closed-end funds and unregistered funds, as well as separate accounts for institutional and high net-worth clients. | Finance |
MPM BioEquities Adviser LLC
MPM BioEquities Adviser LLC Investment ManagersFinance Founded in 1997 by Ansbert Gadicke and Luke Evnin, MPM BioEquities Adviser LLC is a hedge fund manager located in South San Francisco, California with an additional office in Boston. The firm is a subsidiary of MPM Capital LP, a private equity firm. | Finance |
TriVascular, Inc.
TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Health Technology |
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
Alex. Brown & Sons, Inc. | Finance |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Finance |
CFA Society of San Francisco
CFA Society of San Francisco Miscellaneous Commercial ServicesCommercial Services CFA Society of San Francisco provides educational services. It offers a multi-review course which provides structured, classroom-based approach to preparing for the examination. The firm focuses on the assigned materials in the study guides from CFA Institute, with an emphasis on the Learning Outcome Statements (LOS). The company was founded in 1929 and is headquartered in San Francisco, CA. | Commercial Services |
Trivascular Technologies, Inc.
Trivascular Technologies, Inc. Medical SpecialtiesHealth Technology Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA. | Health Technology |
Trivascular2, Inc.
Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Health Technology |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Health Technology |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Qool Therapeutics, Inc.
Qool Therapeutics, Inc. BiotechnologyHealth Technology Qool Therapeutics, Inc. develops non-invasive temperature management therapies to induce therapeutic hypothermia. The company was founded by Amir Belson in 2005 and is headquartered in Menlo Park, CA. | Health Technology |
Oventus Medical Ltd.
Oventus Medical Ltd. Medical SpecialtiesHealth Technology Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. It offers an oral device under the O2Vent brand. The O2Vent unique design directs the air flow through to the back of the throat, alleviating multiple sites of obstruction including the nose, soft palate and tongue The company was founded by Christopher Patrick Hart in 2012 and is headquartered in Indooroopilly, Australia. | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Finance |
- Borsa valori
- Insiders
- Jake Nunn